Presenting Monday through Thursday
908 Devices, Inc.
101. An Integrated Benchtop Analyzer for the Rapid Analysis of Amino Acids, Water Soluble Vitamins, Biogenic
Amines and Dipeptides in Cell Growth Media; Presented
by Kerin G.
908 Devices, Inc.
102. Rapid At-Line Nutrient Profiling from an Ammonia Stressed CHO Cell Line Utilizing an Integrated Benchtop Analyzer; Presented by Glenn H.
AbbVie
103. Optimizing Key Amino Acids in CHO Cell Culture Medium Improves Productivity and Reduces Waste Byproducts for Biologics Manufacturing; Presented by Adam D.
Alphalyse A/S
104. HCP Coverage by Immunocapture and LC-MS/MS; Presented by Ejvind M.
Applied Genetic Technologies Corporation
105. Potency Assay Development for rAAV Vector Encoding ATP Binding Cassette Subfamily D Member 1 Protein (ALDP); Presented by Geeta I.
Applied Photophysics, Inc.
106. More Than Just Alpha-Helix and Beta-Sheet: Expanding the Role of Circular Dichoism; Presented
by Frank Y.
Aragen Bioscience, Inc.
107. An Integrated Stepwise Approach to Developability Assessment of Therapeutic Antibody Candidates from Discovery to Development; Presented by Amisha K.
AstraZeneca
108. Evaluation of a Novel Instrument for Automated Buffer Preparation; Presented by Mariko
C.
AstraZeneca
109. Evaluation of Flocculation as an Impurity Clearance Technique for Improved CHO Cell Culture Harvest; Presented by Valeria R.
Bilfinger Industrietechnik Salzburg GmbH
110. A Software Implementing Quality by Control to Bioprocesses; Presented by Gerald
B.
Bilfinger Industrietechnik Salzburg GmbH
111. Oxygen Uptake Rate Soft-Sensing and Its Application for Biomass and Metabolic Transition Prediction; Presented by Wolfgang S.
Bristol-Myers Squibb
112. Evaluation of a Multimodal Chromatography Capability for Host Cell Protein Clearance; Presented
by Haiying B.
Bristol-Myers Squibb
113. Application of a Relative Transcript Real-Time PCR Method in Predicting High-Expressing Clones During Cell Line Development; Presented by Erik L.
Bristol-Myers Squibb
114. Viscosity in High-Concentration Protein Formulations; Presented by Thomas P.
Bristol-Myers Squibb
115. Influence of Process and Analytical Factors on Charge Heterogeneity in Therapeutic Fusion Proteins; Presented by Ashwitha R.
Bristol-Myers Squibb
116. Anion Exchange Design Space Optimization for Improving Process Robustness and Yield; Presented
by Dong Y.
Celgene Corporation
117. Development of a Rapid Peptide Mapping Method, Using Scaled Down Gradient, to Support Biologics Development; Presented by Nandakumar M.
Chung-Ang University
118. Optimized Production and Quantification of the Sweet-Tasting Protein Brazzein in Kluyveromyces lactis; Presented by Kwang-Hoon K.
Corning, Inc.
119. A Novel Method for AAV Vector Production Using Dissolvable Microcarriers; Presented
by Hannah G.
DAICEL Bioseparations/Chiral Technologies, Inc.
120. DAISEP MabXpure: Innovative Strategies for Enhancing HCP Clearance in Clarification and Downstream Processing of mAbs; Presented by Jerry R.
Development Center for Biotechnology
121. A New CHO Expression System (CHO-C) and Integrated Continuous Bioprocessing Platform for High Yield Mab Production; Presented by Ching-Jen Y.
DuPont
122. Dynamic Properties of a Novel Surfactant for Improved Biologic Stability; Presented
by Susan J.
Fluid Imaging Technologies
123. Comparison of Manual Pipetting Versus Automated Liquid Handler Pipetting into FlowCam; Presented
by Dave H.
Fluid Imaging Technologies
124. FlowCam Nano Provides Counts, Sizes and Images of Nano- and Microparticles: Application to a Therapeutic Protein Pumping Study; Presented by Dave H.
Genentech, Inc.
125. Fast On-Line Characterization of Therapeutic Protein Charge Variants by Multi-Dimensional LC/MS; Presented by Lu D.
GenScript USA, Inc.
126. Biologics and Viral Vectors for IND Application: CMC Platform by GenScript; Presented
by Leon S.
GigaGen, Inc.
127. An Optimized Targeted Integration CHO Cell Line for Manufacturing Polyclonal Antibodies; Presented by Jackson L.
Gilead Sciences, Inc.
128. Applying High Throughput Particle Characterization Methods to Assess the Relative Titer and Physical Stability of Viral Vectors; Presented by Lydia S.
Gyros Protein Technologies
129. Boosting Impurity Detection Productivity Using New Immunoassay Kits for HCP Analysis and Gyrolab® Automated Systems; Presented by Eric F.
Iuliu Hatieganu University of Medicine and Pharmacy
130. Emulsion Monolayer Self-Assembly: A New Tool for Biomolecular Separation and Selective Recovery; Presented by Titus o.
JSR Life Sciences
131. Protein A Chromatography as Capture Step for Antibody Fragments: Mechanism of Interaction and Case Study; Presented by Gary D.
Kaneka Americas Holding
132. Concisely Produced Homogeneous Antibody-Drug Conjugates by A Tryptophan-Selective Protein Bioconjugation; Presented by Harkewal S.
Kite, a Gilead Company
133. Development of a B Cell Flow Cytometric Method Intended for the Characterization of Incoming Patient Apheresis Materials; Presented by Michelle T.
KTH Royal Institute of Technology
134. Optimization of a Calcium-Dependent Protein A-Derived Domain for Mild Antibody Purification;
Presented by Julia S.
Lindy Biosciences, Inc.
135. High-Concentration Suspensions of Protein Particles Produced by Microglassification; Presented
by Michael D.
Lindy Biosciences, Inc.
136. Microglassification: A Novel and Rapid Dehydration Technology; Presented by Adam R.
Lonza Biologics
137. Feedback Control of Fed-Batch Mammalian Cell Culture Using Raman Spectroscopy; Presented
by Brian H.
Magenta Therapeutics
138. Systematic Formulation Development for Antibody Bulk Intermediate for Storage Before ADC Manufacturing; Presented by Ryan K.
MaxCyte, Inc.
139. Strategies for Improved Protein Expression, Production Timelines and Laboratory Productivity Using CHO Cell Transient Expression; Presented by James B.
MaxCyte, Inc.
140. Optimizing HEK and CHO Cell Line Stable Pool Generation Using Scalable Electroporation; Presented
by Joan H.
MaxCyte, Inc.
141. CRISPR-Based Engineering of CHO Cell Lines; Presented by Martin W.
Merck & Co., Inc.
142. Development of a Robust Functional Cell-Based Assay for Replacing the Rabbit Blood Sugar Bioidentity Test of Insulin and Its Analog; Presented by Junming Y.
Microsaic Systems plc
143. The Development of a Point-of-Need Miniaturized ESI-MS for Upstream Bioprocessing Applications; Presented by Alex M.
Molecular Devices, LLC
144. High Throughput Sialylation Measurement on Octet Label Free Instrument for Cell Line Development; Presented by Hongshan L.
Molecular Devices, LLC
145. Combining Single-Cell Isolation and Microplate Imaging to Increase Colony Outgrowth Efficiency with Higher Assurance of Clonality; Presented by Hongshan L.
MorphoSys AG
146. How to Analyze and Influence Self-Interaction Behavior of mAbs - A Case Study; Presented
by Martin D.
NanoCellect Biomedical, Inc.
147. WOLF Cell Sorter for Single-Cell Cloning and Cell Line Development; Presented by Aly
K.
Neofluidics LLC
148. A Low-Volume, Multiplexed Microfluidic Viscometer for Protein Viscosity and Stability Characterization; Presented by Lisa L.
North Carolina State University
149. Development of a Scalable Gene Therapy Vector Production Platform for Bioprocess Research and Training; Presented by Caroline S.
Novadip Biosciences
150. An Allogenic 3D Scaffold-Free Tissue Engineered Product for Deep Thickness Skin Regeneration: In Vitro Development to In Vivo Proof of Concept; Presented by
Nicolas T.
Pennsylvania State University
151. A Two-Step Model for Colloidal Phase Separation in Therapeutic Antibody Solutions;
Presented by Bradley R.
PerkinElmer
152. Detection of AAV Capsid Proteins by CE-SDS as an Alternative to Silver Stain SDS-PAGE; Presented
by Jeray T.
Polyplus-transfection
153. Addressing Large-Scale Therapeutic Virus Production Using High Quality Grade PEI-Based Transfection Reagents; Presented by Jonathan H.
ProZyme, A Part of Agilent
154. An Improved Workflow for Profiling and Quantitation of Sialic Acids in Biotherapeutics; Presented by Anna F.
Sartorius Stedim Biotech GmbH
155. Single-Use Membrane Chromatography in ADC Production: Development of an ADC Process with Single-Use Membrane Chromatography Sartobind® S and Sartobind® Phenyl;
Presented
by Kathryn S.
Sartorius Stedim North America, Inc.
156. Approaches for Applying Perfusion Mimic in the New ambr® 15 Cell Culture Generation 2; Presented
by Ryan C.
Sartorius Stedim North America, Inc.
157. Increased Productivity with Single-Use Membrane Chromatography; Presented by Daniela
S.
SCIEX
158. Quantitative LC-MS/MS Solution for Targeted Cell Culture Media Analysis; Presented by Yi
Z.
Shire HGT, Inc., A Takeda Company
159. Multimodal Chromatography in Fc-Fusion Protein Fragment Removal; Presented by Rongxin
S.
Stanford University
160. Manufacturing and Characterization of Bispecific CD19/22 CAR T for B-Cell Malignancies; Presented
by Shabnum P.
Takeda Pharmaceuticals International, Inc.
161. Evaluation of Gyros xPlore for Higher Throughput Host Cell Protein Measurement; Presented
by Wenlan Y.
Thermo Fisher Scientific, Inc.
162. Automated Foam Control in HyPerforma™ Single-Use Bioreactors Using a Single-Use Foam Probe; Presented by Josh A.
Thermo Fisher Scientific, Inc.
163. Mixing Operations for 50 L to 2000 L Single-Use Mixer: Liquid-Liquid Mixing Characterization and Slurry Suspension; Presented by Josh A.
Thermo Fisher Scientific, Inc.
164. Application-Specific Enhancements to Thermo Scientific HyPerforma Single-Use Bioreactor (S.U.B.); Presented
by Mason S.
Thermo Fisher Scientific, Inc.
165. 12 Month Post Gamma Qualification of Single-Use pH Sensors in Single-Use Bioreactor, Mixer, and Fermenter Equipment; Presented by Mason S.
U.S. Food and Drug Administration
166. Evaluation of the Differentiation Status of Neural Stem Cells Derived from Human iPSCs; Presented
by Ge M.
UBE Industries, Ltd.
167. Continuous Production of IgG, Virus, Recombinant Proteins and Exosomes Using a Novel Membrane Module System; Presented by Masahiko H.
Unchained Labs
168. The New Hound: Three Lasers to ID It All; Presented by Robin S.
Unchained Labs
169. Plug into Fast, Accurate Protein Quantification with Lunatic; Presented by Ross
W.
University of California, San Diego
170. Metabolic Model Predicts Growth Phenotypes of Mammalian Cell Culture; Presented by Matthew
S.
University of Strasbourg
171. Low-Shear Technology Towards Cell Culture Optimization; Presented by Thomas B.
Waters Corporation
172. A Platform Method for the Molecular Mass Analysis of the Light Chains and Heavy Chains of Monoclonal Antibodies; Presented by Steven C.
Waters Corporation
173. Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/Non-Regulated Environments; Presented by John G.
Advanced Instruments
174. Osmolality Is a Predictor for Model Based Real Time Monitoring of Concentration in Protein Chromatography; Presented by Kristeena W.
Genedata, Inc.
175. Efficient Data Processing Workflows for In-Depth, MS-Based Glycoanalysis of Biopharmaceuticals; Presented by David B.
Genedata, Inc.
176. Achieving Operational Efficiency in Bioprocess Development; Presented by Amanda F.
Genedata AG
177. Integrated Sample and Data Management for Micro-Bioreactor Experiments; Presented by Lukasz G.
Genedata, Inc.
178. A Platform Approach to Assess Developability Risks of Biologics; Presented by Andrew L.
Genedata, Inc.
179. Automated Comprehensive Characterization and Quantification of Low-Abundance Sequence Variants in a Standard Monoclonal Antibody; Presented by John M.
Genedata, Inc.
180. Accelerate Clinical Trial Entry by Automating Cell Line Development; Presented by Bernie E.
SCIEX
181. A Quantitative Compliant Multi Attribute Methodology (MAM) LC/MS Workflow; Presented by Matthew S.
Presenting Monday through Tuesday
Bristol-Myers Squibb
201. Sequence Variant Root Cause Identification in CHO Cell Line Generation; Presented by Todd
R.
Seattle Genetics, Inc.
202. Application of Design of Experiments (DoE) in the Development of a Process Specific HCP ELISA; Presented by Jenny W.
Thermo Fisher Scientific, Inc.
203. Strategies for High-Titer Protein Expression Using the ExpiCHO and Expi293 Transient Expression Systems; Presented by Jian L.
Presenting Wednesday through Thursday
Biogen
301. High-Throughput Screening of Adenovirus Infectivity for Accelerated Development; Presented
by Annicka E.
Biogen
302. Encapsidated rAAV Genome Characterization by Next-Generation Sequencing; Presented by Hui-wen
L.
Bristol-Myers Squibb
303. Small-Scale Tools for the Assessment of the Impact of Interfacial and Shear Stress on Biologic Drug Product; Presented by Maria O.
Bristol-Myers Squibb
304. Charge Variants Separation by Free Flow Electrophoresis; Presented by Jun X.
Genedata, Inc.
305. An Enterprise Software Platform to Streamline the Generation, Analysis, and Visualization of Genomic Data in Cell Line Development; Presented by Michael
J.
Genedata, Inc.
306. Adventitious Agent Detection of Biopharmaceuticals Using Next Generation Sequencing and Genedata Selector; Presented by Marcell V.
Leidos Biomedical Research, Inc.
307. A Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing; Presented
by Nagarathinam S.
LEUKOCARE AG
308. Algorithm-Based Formulation Development with DoE Approach to Enable More Stable Liquid Formulations of Therapeutic Antibodies; Presented by Sabine H.
Massachusetts Institute of Technology
309. Establishing a Correlation Between Automated and Manual Sampling in a Cell Culture Bioreactor; Presented by Christa N.
MilliporeSigma
310. Development of a Chemically Defined Medium for Scale Up and a High-Producing HEK293T Clone for Transient Lentivirus Production; Presented by Daiva D.
Purilogics, LLC
311. Case Study: New Affinity Membranes for the Rapid Isolation and Purification of Biologics; Presented by Graham T.
Purilogics, LLC
312. Application of Novel Multimodal Anion-Exchange Membrane Chromatography Columns in a Two-Step mAb Purification Scheme - Aggregates and HCP Removal; Presented by Jinxiang
Z.
Regeneron Pharmaceuticals, Inc.
313. Microfluidic-Based Automated CHO HCP ELISA Enables HCP Quantification During High-Throughput Screening Studies with Small Samples Volumes and a Large Design Space;
Presented
by Samantha W.
SCIEX
314. Method Optimization and Evaluation for RNA Purity Analysis Using CE-LIF Technology; Presented
by James D.
Spheryx, Inc.
315. Distinguishing Protein Aggregates from Contaminants in Viscous Mixtures with Holographic Video Microscopy; Presented by Laura P.
Tenaya Therapeutics
316. AAV Comparability Between HEK293T and Sf9 Cell Production Platforms for Treatment of Heart Diseases; Presented by Charles F.
TetraScience
317. Digital Bioprocessing Scale-Up: The Impact of Instrument and Software Integration; Presented
by Jesus Z.
Thermo Fisher Scientific, Inc.
318. ExpiSf™ Expression System: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells; Presented by Kenneth T.
Ultragenyx
319. Improved Host-Cell Protein Clearance Utilizing Flow-Through Cation Exchange Membrane for AAV Purification; Presented by Mike D.
Ultragenyx
320. Scale-Up and Conversion of an Adherent AAV Manufacturing Process to a Higher-Producing and Scalable Suspension Platform; Presented by
University of Miami
321. Bioprocess Optimization of Nucleus Pulposus Derived Spheroid Production in Stirred-Tank Reactors; Presented by Daniel R.
University of Rochester Medical Center
322. Cell Therapy Manufacturing the Upstate Stem Cell cGMP Facility; Presented by Luisa
C.
US Pharmacopeia
323. Characterization of USP Oligosaccharide System Suitability Mixture A and Mixture B Reference Standards; Presented by Tim G.